This content is from: Premium

Icahn Alum Alex Denner Thrives on Popping Drug Stocks

Sarissa Capital Management is one of the top performing activists so far this year.

      Alex Denner, Sarissa Capital Management (photo credit: Andrew Harrer/Bloomberg) Sarissa Capital Management’s chief investment officer Alexander Denner knows very well that specializing in drug, biotech and other health care stocks can be volatile. This year is a prime example. The Icahn Capital alum and Tiger grandcub runs one of the top-performing

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content